Gurley says lobbyists from regulated companies literally talk to congressmen about what goes into new laws.
“If they're striking a new federal law, like the lobbyists from the companies being regulated are on M Street talking to the congressman about what to put into the bill.”
Gurley argues NIH-funded research should be open source rather than becoming proprietary.
“Why wouldn't we say if you take NIH dollars, your research is open source? Why do we use government dollars to fund stuff that becomes proprietary? That doesn't make any sense to me.”